Elevation Oncology Statistics
Total Valuation
ELEV has a market cap or net worth of $18.77 million. The enterprise value is -$30.64 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ELEV has 59.22 million shares outstanding. The number of shares has increased by 35.68% in one year.
| Current Share Class | 59.22M |
| Shares Outstanding | 59.22M |
| Shares Change (YoY) | +35.68% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 39.52% |
| Float | 43.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.40, with a Debt / Equity ratio of 0.67.
| Current Ratio | 19.40 |
| Quick Ratio | 19.04 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.80 |
Financial Efficiency
Return on equity (ROE) is -78.32% and return on invested capital (ROIC) is -30.93%.
| Return on Equity (ROE) | -78.32% |
| Return on Assets (ROA) | -29.86% |
| Return on Invested Capital (ROIC) | -30.93% |
| Return on Capital Employed (ROCE) | -58.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.41M |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELEV has paid $38,000 in taxes.
| Income Tax | 38,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.53% in the last 52 weeks. The beta is 1.61, so ELEV's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -91.53% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.56 |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | 858,358 |
Short Selling Information
The latest short interest is 3.62 million, so 6.12% of the outstanding shares have been sold short.
| Short Interest | 3.62M |
| Short Previous Month | 8.63M |
| Short % of Shares Out | 6.12% |
| Short % of Float | 8.33% |
| Short Ratio (days to cover) | 3.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -45.68M |
| Pretax Income | -39.66M |
| Net Income | -47.99M |
| EBITDA | -45.66M |
| EBIT | -45.68M |
| Earnings Per Share (EPS) | -$0.81 |
Full Income StatementBalance Sheet
The company has $80.66 million in cash and $31.25 million in debt, giving a net cash position of $49.41 million or $0.83 per share.
| Cash & Cash Equivalents | 80.66M |
| Total Debt | 31.25M |
| Net Cash | 49.41M |
| Net Cash Per Share | $0.83 |
| Equity (Book Value) | 46.73M |
| Book Value Per Share | 0.79 |
| Working Capital | 77.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -39.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | -39.50M |
| FCF Per Share | -$0.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |